Detailed statistical analysis plan for the SafeBoosC III trial: a multinational randomised clinical trial assessing treatment guided by cerebral oxygenation monitoring versus treatment as usual in extremely preterm infants

BACKGROUND: Infants born extremely preterm are at high risk of dying or suffering from severe brain injuries. Treatment guided by monitoring of cerebral oxygenation may reduce the risk of death and neurologic complications. The SafeBoosC III trial evaluates the effects of treatment guided by cerebra...

Descripción completa

Detalles Bibliográficos
Autores principales: Hansen, Mathias Lühr, Pellicer, Adelina, Gluud, Christian, Dempsey, Eugene, Mintzer, Jonathan, Hyttel-Sorensen, Simon, Heuchan, Anne Marie, Hagmann, Cornelia, Dimitriou, Gabriel, Pichler, Gerhard, Naulaers, Gunnar, Cheng, Guoqiang, Vilan, Ana, Tkaczyk, Jakub, Kreutzer, Karen B., Fumagalli, Monica, Claris, Olivier, Fredly, Siv, Szczapa, Tomasz, Lange, Theis, Jakobsen, Janus Christian, Greisen, Gorm
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Update
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6921567/
https://www.ncbi.nlm.nih.gov/pubmed/31856902
http://dx.doi.org/10.1186/s13063-019-3756-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6921567/
https://www.ncbi.nlm.nih.gov/pubmed/31856902
http://dx.doi.org/10.1186/s13063-019-3756-y

Ejemplares similares